Established in 1963, Mercury Medical is a specialty healthcare organization featuring airway management devices and dedicated to bringing innovative medical devices to the market. On April 6th Mercury Medical announced the donation of 2,500 Flow-Safe II® Disposable CPAP devices to the state of New York for treating COVID-19 patients. The FDA recently issued guidelines indicating that BiPAP and CPAP devices can be used to effectively help treat COVID-19 patients in Respiratory Distress. CPAP therapy has been shown to be very efficacious in preventing these patients from deteriorating to the point where they require mechanical ventilation. With the current shortage of mechanical ICU ventilators, these CPAP devices can play an important role in meeting New York's surge capacity to treat the influx of COVID-19 patients. The New York City Fire Department (FDNY) has been using Mercury Medical’s Flow-Safe II EZ® disposable CPAP device for patients exhibiting symptoms of Respiratory Distress for the last few years. We want to do our part to assist clinicians throughout New York during this pandemic crisis.